Key Notes
- More than 10 suppliers plan a care robot council before the end of 2026.
- Safety, liability and home-data rules are among its reported priorities.
- South Korea’s existing AI care strategy supports research, field trials and commercialization alongside legal and workforce measures.
More than 10 South Korean care robot companies are preparing to form a wellness robot council before the end of 2026, seeking clearer rules that could help move the industry beyond publicly funded trials.
SK Intellix, Hyodol and Roaizen are among the participants, Seoul Economic Daily reported on October 6. The Korea AI and Robot Industry Association would act as secretariat and present industry views to government agencies.
A Push for Clearer Care Robot Rules
The proposed council wants changes to the Intelligent Robots Act. Companies told the newspaper that indoor care robots need clearer definitions, safety requirements, accident liability and rules governing information collected in homes.
The report also identifies uncertainty over reimbursement and staffing incentives as obstacles to adoption. Forming a council would give suppliers a common channel for those requests; it would not itself change the rules under which care facilities operate.
Government Strategy Already Includes Regulatory Work
South Korea’s health and science ministries announced an AI care technology strategy on April 16. The government’s account describes support running from research through field testing and commercialization, alongside work on legal foundations, ethics guidelines and staff training.
Its near-term approach includes connected smart homes and facilities that use AI and sensors to assist with monitoring and repetitive recordkeeping. Longer-term plans extend to physical AI for mobility and hands-on assistance. Living-lab trials are intended to test effectiveness before technologies spread.
Seoul Economic Daily reports that the health ministry’s proposed 2027 budget includes 37.7 billion won for care robot deployment and commercialization support. That is a budget proposal, rather than evidence that a commercial market has already been established.
Care Robots Cover Different Kinds of Work
Care robotics encompasses more than a mobile machine that lifts or carries objects. Hyodol’s company platform, for example, emphasizes companionship, daily routines and safety support, combining a companion robot with connected services.
The distinction matters for testing. A conversational device and equipment that physically assists a person require different evidence about performance and risk. Shared industry terminology can help buyers understand which task a product actually supports.
RobotsBeat previously covered Seoul’s nursing facility pilot, which pairs monitoring technologies with equipment for reducing physically demanding care work. It illustrates the range of tools that can appear under the broader care technology label.
Commercial Adoption Needs More Than a Pilot
For suppliers, trials can demonstrate a useful task, but sustained adoption also requires funding, maintenance and a workable role for care staff. Procurement decisions need evidence from daily use, including how equipment fits a facility’s routines and how workers respond when something goes wrong.
South Korea is also developing a domestic humanoid platform for healthcare and residential care, previously covered by RobotsBeat. The proposed council addresses a different part of that effort: the institutional conditions needed to turn technical progress into continuing demand.
Disclaimer: RobotsBeat is an independent media brand owned and operated by NuvexMedia LLC, publishing news, research, and insights on artificial intelligence, emerging technologies, automation, and related industries. NuvexMedia LLC invests in and collaborates with companies across the AI, Robotics, technology, software, and digital innovation sectors. These relationships do not influence RobotsBeat's editorial coverage, and the publication maintains full editorial independence to provide accurate, timely, and objective information. © 2026 NuvexMedia LLC. All rights reserved. This content is for informational purposes only and should not be considered legal, tax, investment, financial, or other professional advice.
